ArticleJournal of the Royal Society of Medicine2006
Diabetes management in the USA and England: comparative analysis of national surveys.
Article in Journal of the Royal Society of Medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 40 citations in OpenAlex.
- Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.Cardiovascular diabetology · 2020 · on this mapObservational
- Medicaid Eligibility Expansions May Address Gaps In Access To Diabetes Medications.Health affairs (Project Hope) · 2018Article
- Current status of glucose, blood pressure and lipid management in type 2 diabetes clinic attendees in Isfahan, Iran.Journal of diabetes investigation · 2015Article
- Mortality and excess risk in US adults with pre-diabetes and diabetes: a comparison of two nationally representative cohorts, 1988-2006.Population health metrics · 2013Article
- Income inequality in health at all ages: a comparison of the United States and England.American journal of public health · 2012Article
- Access to health care and control of ABCs of diabetes.Diabetes care · 2012Article
- An evaluation of Birmingham Own Health telephone care management service among patients with poorly controlled diabetes. A retrospective comparison with the General Practice Research Database.BMC public health · 2011Article
- Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys.Bulletin of the World Health Organization · 2011Article
- A comparison of chronic illness care quality in US and UK family medicine practices prior to pay-for-performance initiatives.Family practice · 2009Article
- In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes.Journal of diabetes science and technology · 2008Article
- Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool.Journal of diabetes science and technology · 2008Article
- Optimizing diabetes care: perspectives from a practical view point.Journal of the Royal Society of Medicine · 2007Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
objectivesTo compare diabetes management in adults between England and the United States, particularly focusing on the impact of a universal access health insurance system.
designAnalysis of the nationally-representative surveys Health Survey of England, 2003 (unweighted n =14 057) and the National Health and Nutrition Examination Survey, 2001-2002 (unweighted n =5411). SETTING AND
participantsAdults 20-64 years of age; individuals >65.
main outcome measuresGlycaemic, lipid and blood pressure control and medication use among individuals with previously diagnosed diabetes.
resultsAmong those aged 20-64 the prevalence of diagnosed diabetes was lower in England (2.7%) than in the USA (5.0%). The proportion with diabetes receiving treatment was similar for the two countries. However, the mean HbA1c in England was 7.6%: in the USA it was 7.5% for those with insurance and 8.6% for those without insurance. The proportion of individuals on ACE inhibitors in England was 39%: in USA it was 39% for those with insurance, and 14% for those without.
conclusionsIndividuals in a healthcare system providing universal access have better managed diabetes than those in a market based system once one accounts for insurance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.